New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism

被引:357
作者
Eid, Stephanie [1 ]
Sas, Kelli M. [2 ]
Abcouwer, Steven F. [3 ]
Feldman, Eva L. [1 ]
Gardner, Thomas W. [3 ,4 ]
Pennathur, Subramaniam [2 ,4 ]
Fort, Patrice E. [3 ,4 ]
机构
[1] Univ Michigan, Dept Neurol, Ann Arbor, MI USA
[2] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA
[4] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Diabetes; Diabetic complications; Lipid metabolism; Omics; Review; Specific mechanisms; KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; GLUCOSE CONTROL; OXIDIZED LDL; RISK-FACTORS; KEY ROLE; RETINOPATHY; TYPE-1; PROGRESSION;
D O I
10.1007/s00125-019-4959-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes adversely affects multiple organs, including the kidney, eye and nerve, leading to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy, respectively. In both type 1 and type 2 diabetes, tissue damage is organ specific and is secondary to a combination of multiple metabolic insults. Hyperglycaemia, dyslipidaemia and hypertension combine with the duration and type of diabetes to define the distinct pathophysiology underlying diabetic kidney disease, diabetic retinopathy and diabetic neuropathy. Only recently have the commonalities and differences in the metabolic basis of these tissue-specific complications, particularly those involving local and systemic lipids, been systematically examined. This review focuses on recent progress made using preclinical models and human-based approaches towards understanding how bioenergetics and metabolomic profiles contribute to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy. This new understanding of the biology of complication-prone tissues highlights the need for organ-specific interventions in the treatment of diabetic complications.
引用
收藏
页码:1539 / 1549
页数:11
相关论文
共 115 条
[1]   Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment [J].
Abcouwer, Steven F. ;
Gardner, Thomas W. .
YEAR IN DIABETES AND OBESITY, 2014, 1311 :174-190
[2]   Lipidomics and Biomarker Discovery in Kidney Disease [J].
Afshinnia, Farsad ;
Rajendiran, Thekkelnaycke M. ;
Wernisch, Stefanie ;
Soni, Tanu ;
Jadoon, Adil ;
Karnovsky, Alla ;
Michailidis, George ;
Pennathur, Subramaniam .
SEMINARS IN NEPHROLOGY, 2018, 38 (02) :127-141
[3]   Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD [J].
Afshinnia, Farsad ;
Rajendiran, Thekkelnaycke M. ;
Soni, Tanu ;
Byun, Jaeman ;
Wernisch, Stefanie ;
Sas, Kelli M. ;
Hawkins, Jennifer ;
Bellovich, Keith ;
Gipson, Debbie ;
Michailidis, George ;
Pennathur, Subramaniam .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (01) :295-306
[4]   Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort [J].
Afshinnia, Farsad ;
Rajendiran, Thekkelnaycke M. ;
Karnovsky, Alla ;
Soni, Tanu ;
Wang, Xue ;
Xie, Dawei ;
Yang, Wei ;
Shafi, Tariq ;
Weir, Matthew R. ;
He, Jiang ;
Brecklin, Carolyn S. ;
Rhee, Eugene P. ;
Schelling, Jeffrey R. ;
Ojo, Akinlolu ;
Feldman, Harold ;
Michailidis, George ;
Pennathur, Subramaniam .
KIDNEY INTERNATIONAL REPORTS, 2016, 1 (04) :256-268
[5]   A mitochondrial therapeutic reverses visual decline in mouse models of diabetes [J].
Alam, Nazia M. ;
Mills, William C. ;
Wong, Aimee A. ;
Douglas, Robert M. ;
Szeto, Hazel H. ;
Prusky, Glen T. .
DISEASE MODELS & MECHANISMS, 2015, 8 (07) :701-710
[6]  
[Anonymous], 2018, WECHATS ANN DATA REP
[7]  
[Anonymous], 2017, DIAB FACTS FIG
[8]   Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS) [J].
Ansquer, JC ;
Foucher, C ;
Rattier, S ;
Taskinen, MR ;
Steiner, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (03) :485-493
[9]   Enhanced glucose control for preventing and treating diabetic neuropathy [J].
Callaghan, B. C. ;
Little, A. A. ;
Feldman, E. L. ;
Hughes, R. A. C. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (06)
[10]   Diabetes and obesity are the main metabolic drivers of peripheral neuropathy [J].
Callaghan, Brian C. ;
Gao, LeiLi ;
Li, Yufeng ;
Zhou, Xianghai ;
Reynolds, Evan ;
Banerjee, Mousumi ;
Pop-Busui, Rodica ;
Feldman, Eva L. ;
Ji, Linong .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (04) :397-405